Weekly Digest – January 2026 Weekly Digest – January 2026 29 January 2026: MT-2111 (loncastuximab tesirine-lpyl) achieved primary endpoint in phase 2 part of Japanese phase 1/2 study for relapsed or refractory Diffuse Large B-cell Lymphoma Tanabe Pharma announced a […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id